U.S. Markets close in 3 hrs 34 mins

Glenmark Pharmaceuticals Limited (GLENMARK.NS)


NSE - NSE Real Time Price. Currency in INR
Add to watchlist
627.90+0.85 (+0.14%)
At close: 3:29PM IST
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Revenue3/31/20173/31/20163/31/20153/31/2014
Total Revenue91,857,00075,460,00065,561,00059,450,000
Cost of Revenue26,143,00023,668,00019,435,00021,379,000
Gross Profit65,714,00051,792,00046,126,00038,071,000
Operating Expenses
Research Development----
Selling General and Administrative----
Non Recurring----
Others----
Total Operating Expenses74,285,00063,644,00057,731,00048,390,000
Operating Income or Loss17,572,00011,817,0007,830,00011,060,000
Income from Continuing Operations
Total Other Income/Expenses Net----
Earnings Before Interest and Taxes17,572,00011,817,0007,830,00011,060,000
Interest Expense-2,373,000-1,789,000-1,902,000-1,886,000
Income Before Tax----
Income Tax Expense3,442,0003,028,0001,190,0001,513,000
Minority Interest----
Net Income From Continuing Ops----
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income9,159,0007,021,0004,753,0005,423,000
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares----